SAB Archives - A2 Biotherapeutics

A2 Bio Clinical Advisory Board Frederick Locke, MD

Frederick Locke, MD Moffitt Cancer Center, Blood and Marrow Transplant and Cellular Immunotherapy

A2 Bio Clinical Advisory Board Marco Davila M.D., Ph.D.

Marco Davila, M.D., Ph.D. Roswell Park Comprehensive Cancer Center, Medical Oncology

A2 Bio Science Advisory Board Marcela Maus

Marcela Maus, M.D., Ph.D. Harvard University, Translational Cell Therapy

A2 Bio Science Advisory Board George Tsokos

George C. Tsokos, M.D. Harvard University, T cell Biology

A2 Bio Science Advisory Board David Maloney

David Maloney, M.D., Ph.D. Fred Hutchinson Cancer Center, Cancer Cell Therapy

A2 Bio Science Advisory Board Robert Schreiber

Robert Schreiber, Ph.D. Washington University, Immunology & Neo-antigens

A2 Bio Science Advisory Board Mark Davis

Mark Davis, Ph.D. Stanford, Human Immunology & TCRs

William Go, M.D., Ph.D. Chief Development Officer of BioMarin